Abbott India Ltd - Company Profile
Powered by 
All the sales intelligence you need on Abbott India Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abbott India Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abbott India Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, develops, manufactures, and distributes science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. The company's major activities revolve around translating science into lasting contributions to health, with a focus on diverse therapeutic areas such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care. Its product portfolio encompasses multi-speciality drugs, vitamins, and products for the treatment of epilepsy, hypothyroidism, vertigo, migraine, and depression. The company also provides vaccines for influenza, typhoid, and diarrhoea. Abbott India develops pharmaceuticals in various formulations, including tablets, injectables, liquids, ointments, granules, powder, and capsules. The product range helps treat gynaecological, gastroenterological, urological, and neurological diseases, diabetes, pain, and infection. The company has a manufacturing facility in Goa, India. Abbott India is headquartered in Mumbai, Maharashtra, India.
Abbott India Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Allergy: | Arachitol |
| Solspre | Brufen |
| Ebasil | Cremaffin |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In May, the company launched Ensure Strength Pro, a scientifically designed blend of nutrients to support strength and overall well being. |
| 2026 | New Products/Services | In May, the company launched TriClip transcatheter edge-to-edge repair (TEER) system in India. |
| 2026 | New Products/Services | In March, the company launched XIENCE Skypoint. |
Competitor Comparison
| Key Parameters | Abbott India Ltd | Dr. Reddy's Laboratories Ltd | Aurobindo Pharma Ltd | Cipla Ltd | Lupin Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Hyderabad | Hyderabad | Mumbai | Mumbai |
| State/Province | Maharashtra | Telangana | Telangana | Maharashtra | Maharashtra |
| No. of Employees | 3,679 | 27,527 | 29,209 | 31,369 | 26,021 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Sudarshan Jain | Chairman | Executive Board | 2019 | - |
| Maithilee Pathare Mistry | Chief Financial Officer | Senior Management | 2025 | - |
| Kartik Rajendran | Managing Director; Director | Executive Board | 2025 | 47 |
| Vivek Mohan | Director; Vice President | Executive Board | 2026 | - |
| Sangeeta Shetty | Compliance Officer; Secretary | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer